The cluster of differentiation (CD) antigen CD28 is a 44-kDa, disulphi
de-bonded, homodimeric glycoprotein, which is constitutively expressed
on the surface of all murine T cells and the majority of human T cell
s. Ligation of CD28 by its counter receptor, B7, expressed on the surf
ace of antigen presenting cells, has been shown to induce signals that
, in synergy with those derived from engagement of the T cell receptor
by an antigen bound to a major histocompatibility complex, enhance pr
oliferation and cytokine production. Manipulation of this interaction
can have dramatic effects on the outcome of T cell activation. Blockin
g CD28/B7 interactions may be useful in preventing unwanted activation
in allergy and autoimmune diseases, whereas enhancing this interactio
n can promote tumour rejection. Thus, CD28 and its signalling pathways
may prove to be useful targets in the development of new therapeutic
treatments. (C) 1997 Elsevier Science Ltd.